Wednesday, October 24, 2018 7:03:04 PM
It is the first time - quite unexpectedly from what I gather - that the abscopal effect generated by intratumoral administration of encoded IL-12 genes noticeably lacked exhaustion markers in tumor infiltrating lymphocytes found in untreated tumors. Typically this only happens during acute situations. If the new p2a-linked plasmid construct coupled with modified electroporation parameters has something to do with the significant improvements in intratumoral IL-12 expression and armoring of effector cells, then this is definitely a big deal. Obviously, just like everything else in immunology, the observations would need to translate into humans. But if it does, it could potentially negate the need for systemic anti-pd-1 agents!
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM